baber/WOPTO huggingface dataset:
Patent AU-2005272074-B2 (AU)
Title: Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
Inventor: BERNHARD PAUL
IPC: C07D401/06
Filed: 2005-06-22
Granted: 2011-11-24
Abstract: Crystalline polymorphs of (3 R)-1-(2-methylalanyl-D-tryptophyl)-3­ (phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide which are useful as pharmaceutical agents are disclosed. Methods of production and isolation of these polymorphs and pharmaceutical compositions which include these polymorphs and pharmaceutical methods of treatment are also disclosed. The crystalline polymorphs of the present invention are useful as they act directly on the pituitary gland cells to release growth hormone.
Patent AU-2005325807-B2 (AU)
Title: Cervical Intervertebral Prosthesis
Inventor: ARNOLD KELLER
IPC: A61F2/44
Filed: 2005-09-19
Granted: 2011-12-01
Abstract: Disclosed is a cervical intervertebral prosthesis comprising two connecting plates (1, 5) that are to be attached to one of the adjacent vertebral bodies, respectively, and a joint core (20). Said joint core (20) forms a joint along with one connecting plate (1), said joint being provided with a concave joint surface (11) on the joint core (20) and a complementary convex joint surface on the connecting plate (1). The joint core (20) rests on the other connecting plate (5) via a sliding surface (17) which extends substantially parallel to the direction of the connecting plate (5), makes a relative movement in said direction possible, and is surrounded by an edge (15) that limits said relative movement. The concave joint surface (11) encompasses the convex joint surface at a solid angle (28) of at least 90°. The section of the concave joint surface (11) which lies inside said solid angle lies within the recess (16) that is enclosed by the edge (15), thus increasing the stability of the prosthesis relative to laterally applied forces.
Patent AU-2005337613-B2 (AU)
Title: Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
Inventor: PIPKIN JAMES D
IPC: A61K31/715
Filed: 2005-10-26
Granted: 2011-04-28
Abstract: A particulate SAE-CD composition is provided. The SAE-CD composition has an advantageous combination of physical properties not found in known solid forms of SAE-CD. In particular, the SAE-CD composition possesses an advantageous physicochemical and morphological property profile such that it can be tailored to particular uses. The SAE-CD composition of the invention has improved flow and dissolution performance as compared to known compositions of SAE-CD.
Patent AU-2006214141-B2 (AU)
Title: Sample preparation method incorporating an alkaline shock
Inventor: BECKER MICHAEL M
IPC: C12N15/10
Filed: 2006-02-17
Granted: 2010-07-15
Abstract: Method of preparing a biological sample appropriate for use in a subsequent in vitro nucleic acid amplification reaction. The method involves a rapid, transient exposure to alkaline conditions which can be achieved by mixing an alkaline solution with a pH-buffered solution that includes a detergent and the biological sample to be tested for the presence of particular nucleic acid species using in vitro amplification. The invention method advantageously can improve detection of some target nucleic acids without substantially compromising detectability of others. The method is particularly useful for simultaneously preparing RNA and DNA templates that can be used in multiplex amplification reactions.
Patent AU-2006220365-B2 (AU)
Title: Process and apparatus for stamping a pattern onto a coated frozen confection
Inventor: THIELKER HOLGER
IPC: A23P1/08
Filed: 2006-09-18
Granted: 2009-05-07
Abstract: A process for stamping a pattern onto a coated frozen confection is provided, the process comprising the steps of: at least partially covering the frozen confection with a layer of coating; and bringing a stamping surface into contact with the coated frozen confection; characterised in that that the stamping surface is resiliently mounted on a support. An apparatus for stamping a pattern onto a coated frozen confection is also provided.
Patent AU-2006227581-B2 (AU)
Title: Security element
Inventor: HARALD DEINHAMMER
IPC: B42D15/00
Filed: 2006-03-16
Granted: 2011-07-07
Abstract: The invention relates to a security element (1), comprising a first luminescent substance, for a security document (5), the latter (5) comprising a base body (51) consisting of a base material. The aim of the invention is to increase the protection against forgery. To achieve this: the security element is provided with a second luminescent substance; energy is transmitted between the first luminescent substance and the second luminescent substance, whereby the frequency range of the excitation of one of the luminescent substances corresponds to the emission frequency range of the other luminescent substance; and the first luminescent substance is thermally unstable at the ignition temperature of the base material and/or at a temperature of 185 °C.
Patent AU-2006243214-B2 (AU)
Title: Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group
Inventor: CHITI GIACOMO
IPC: C07D487/22
Filed: 2006-05-04
Granted: 2011-05-19
Abstract: A process is described for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group, products useful as photosensitizing agents in photodynamic therapy.
Patent AU-2006246481-B2 (AU)
Title: Composition for the permanent shaping of human hair
Inventor: WOOD JONATHAN
IPC: A61K8/22
Filed: 2006-11-30
Granted: 2012-09-06
Abstract: Summary The present invention concerns a composition for the permanent shaping of human hair used both for the permanent waving of human hair with an excellent waving effect as well as for the straightening of curled hair comprising at least one ubichinone of the formula n where n is a number between 1 and 10 at a concentration of 0.0001 to 1% by weight calculated to total composition.
Patent AU-2006302979-B2 (AU)
Title: Heavy wax stimulation diverting agent
Inventor: BRADEN JOHN C
IPC: E21B43/04
Filed: 2006-09-25
Granted: 2012-02-23
Abstract: A method and composition for isolating a selected subterranean formation in a subterranean formation having a gravel pack over a plurality of producing zones.
Patent AU-2007200981-B2 (AU)
Title: Medical tube
Inventor: ABE KAZUHIRO
IPC: A61M25/01
Filed: 2007-03-06
Granted: 2009-12-10
Abstract: The present invention provides a medical tube having a main body portion (10) and a steerable distal portion (20) made from the same material as the distal portion. A plurality of lumens (13, 14) extend through the main body portion including guide wire lumens through which guide wires (17a) extend from the steerable distal portion to a contol device at a proximal end of the main body portion.
Patent AU-2007248170-B2 (AU)
Title: Fiber photovoltaic devices and applications thereof
Inventor: CARROLL DAVID L
IPC: H01L51/00
Filed: 2007-05-01
Granted: 2012-08-16
Abstract: The present invention relates to organic optoelectronic devices and, in particular, to organic photovoltaic devices having a fiber structure. In one embodiment, a photovoltaic device comprises a first electrode comprising an indium tin oxide fiber, at least one photosensitive organic layer surrounding the first electrode and electrically connected to the first electrode, and a second electrode surrounding the organic layer and electrically connected to the organic layer.
Patent AU-2007249679-B2 (AU)
Title: Furanone-initiated polymers
Inventor: STOPEK JOSHUA B
IPC: C12P21/06
Filed: 2007-05-14
Granted: 2012-11-01
Abstract: Polymers initiated with furanones and compositions containing such polymers are suitable for use in making textiles, medical devices, delivery agents, packaging materials, coatings for such items, and the like.
Patent AU-2007260067-B2 (AU)
Title: Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
Inventor: MACDONALD SIMON JOHN FAWCETT
IPC: C07D231/38
Filed: 2007-06-11
Granted: 2012-10-04
Abstract: The present invention provides compounds of formula (I): a process for their preparation, to pharmaceutical compositions comprising the compounds and the preparation of said compositions, to intermediates and to use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation, allergy and/or auto-immune conditions.
Patent AU-2007303731-B2 (AU)
Title: Feed additive composition for ruminants and method of producing the same
Inventor: MIYAZAWA YUKI
IPC: A23K1/16
Filed: 2007-10-04
Granted: 2014-02-27
Abstract: A food additive composition for ruminants of the dispersion type and a method of continuously producing the same. This food additive composition for ruminants, which contains 40% by weight or more but less than 65% by weight of a basic amino acid and has rumen bypass properties, is formulated into granules in an arbitrary shape which are scarcely classified when added to a silage or another feed. Thus, attempts have been made to develop a method of producing granules by which the milk yield of a lactation cow can be increased. Namely, it is intended to provide a food additive composition for ruminants which contains at least one protecting agent selected from among a hardened vegetable oil and a hardened animal oil having a melting point higher than 50
Patent AU-2007325280-B2 (AU)
Title: Combination of IAP inhibitors and FLT3 inhibitors
Inventor: ZAWEL LEIGH
IPC: A61K31/553
Filed: 2007-11-27
Granted: 2011-03-10
Abstract: The present invention relates to methods of treating hematological malignancies, including acute myeloid leukemia (AML), comprising the combination of a compound that inhibits the binding of the Smac protein to IAPs ("IAP inhibitor") and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; and a commercial package comprising said combination. The present invention also relates to the use of IAP inhibitors in combination with one or more pharmaceutically active agents for the preparation of a medicament to treat hematological malignancies, including AML.
Patent AU-2007347133-B2 (AU)
Title: A hollow syringe barrel and and syringe-in-syringe mixing system
Inventor: SHEETZ JARED
IPC: B65D25/08
Filed: 2007-04-26
Granted: 2013-02-07
Abstract: A hollow inner plunger (100) for use within a syringe-in-syringe mixing system for mixing a two-part dental composition. The hollow inner plunger includes a body having a continuous cylindrical wall (102) defining an internal chamber (108) for containing a first component (HOa). The body (100) includes a proximal end (104) and a distal end (106). A sealing plug and rupturable membrane (116) are disposed at the distal end of the body, and the sealing plug and rupturable membrane (116) are integrally formed together as a single piece (e.g., formed of a single piece of elastomeric material). An associated syringe-in-syringe mixing system (124) includes a first plunger (126), the hollow inner plunger (100), and a syringe barrel (128) configured to contain a second component (HOb). When assembled, the first plunger (126) is slidably disposed within the hollow inner plunger (100), and the hollow inner plunger (100) is slidably disposed within the syringe barrel (128). The two components (110a, 110b) are initially separated by the rupturable membrane (116).
Patent AU-2007356525-B2 (AU)
Title: Self-assembling amphiphilic polymers as anticancer agents
Inventor: ONTON ANN LOUISE
IPC: A61K31/74
Filed: 2007-07-19
Granted: 2014-07-17
Abstract: The invention provides amphiphilic biocompatible copolymers which have a hydrophilic backbone and pendant hydrophobic groups. The polymers form nanoscale molecular aggregates in aqueous environments, which have hydrophobic interiors within which anticancer drugs may be solubilized. The polymers optionally feature attached antibodies, receptor ligands, and other targeting moieties which mediate adherence of the drug-carrying aggregates to targeted cancer cells.
Patent AU-2008204730-B2 (AU)
Title: Boron transporter
Inventor: LANGRIDGE PETER
IPC: C07K14/415
Filed: 2008-01-11
Granted: 2013-08-01
Abstract: The present invention relates to boron transporters and, in particular, to boron transporters derived from plants. The present invention also relates to methods that utilise boron transporters, such as methods for modulating boron transport in cells and methods for determining the level or rate of boron transport in a cell or organism on the basis of the expression level of one or more boron transporters.
Patent AU-2008207851-B2 (AU)
Title: System and method for evaluating equipment rack cooling performance
Inventor: VANGILDER JAMES W
IPC: H05K7/20
Filed: 2008-01-24
Granted: 2011-11-24
Abstract: Aspects of the invention are directed to systems and methods for designing and analyzing data centers. One aspect is directed to a method of determining cooling characteristics of a data center. The method includes receiving data related to a configuration of equipment in the data center, identifying rack clusters in the configuration of equipment, and determining a capture index for at least one equipment rack of at least one rack cluster.
Patent AU-2008229667-B2 (AU)
Title: Constrained orthopaedic prosthesis
Inventor: ROMEIS KRISTEN L
IPC: A61F2/38
Filed: 2008-09-30
Granted: 2013-02-07
Abstract: -21 An orthopaedic prosthesis includes a tibial bearing, a femoral component, and a hinge post coupled to the tibial bearing and the femoral component. The hinge post includes a medial and lateral axle. A pair of bushings 5 are coupled to the axles and received in an internal chamber of the femoral component. The prosthesis may also include a plug received in the internal chamber and positioned to secure the hinge post to the femoral component. The femoral component is configured to rotate about an axis defined by the axles. In some embodiments, the femoral component may include a housing and a patella bearing 10 separate from the housing. 30/09/ ,va 17542 speei,21 Fig. 1
Patent AU-2008243262-B2 (AU)
Title: Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
Inventor: HOWELL M TERRENCE
IPC: A61P43/00
Filed: 2008-11-14
Granted: 2012-01-19
Abstract: A composition comprising a pharmaceutical grade preparation of hops extract comprising an effective amount of tetrahydroisohumulone, and an effective amount of at 5 least one component selected from the group consisting of essential oils, fats and waxes, wherein said pharmaceutical grade extract provides 10 to 95 weight % of tetrahydroisohumulone of the composition. N.\risbaneCases\Patent100(Mi1999\P51597.AU.1\Specis\P51597.AU.1 Speafication 2008-11-14.doc 14/1108
Patent AU-2008243999-B2 (AU)
Title: An item of footwear
Inventor: KILGORE MARCIA
IPC: A43B7/14
Filed: 2008-04-28
Granted: 2012-08-02
Abstract: An item of footwear for increasing leg-muscle and/or lower-abdominal-/back-muscle tone comprising: a securing means for securing the item of footwear to a foot of a user; and a sole comprising at least an upper layer, for engaging a foot of a user in use 'or a further upper layer, and a lower layer, for engaging the ground in use, wherein the upper layer comprises two or more materials of different compressive resistances, or densities, arranged as a frontal/toe region, an arch region and a heel region, the sole is arranged such that application of a user's weight, during use, causes instability in at least one portion of the upper layer, which requires balance correction by a user.
Patent AU-2008283781-B2 (AU)
Title: A low-temperature, moving bed catalytic reactor for control of NOx emissions from coal combustion
Inventor: ROGERS KEVIN J
IPC: C01B21/02
Filed: 2008-08-04
Granted: 2013-01-31
Abstract: An apparatus for low-temperature N O
Patent AU-2008318690-B2 (AU)
Title: Methods for prognosing the ability of a zearalenone analog compound to treat cancer
Inventor: WANG JOHN YUAN
IPC: G01N33/50
Filed: 2008-10-29
Granted: 2015-08-13
Abstract: The instant invention provides methods of prognosing the ability of a zearalenone analog compound to treat a cancer in a subject, methods of prognosing the ability of a zearalenone analog compound to inhibit the growth of a cancer in a subject, and methods of prognosing the ability of a zearalenone analog compound to promote the activation of apoptosis of a cancer in a subject. Methods of treating a cancer in a subject are also provided. The invention also pertains to methods of determining whether a cancer in a subject is sensitive to treatment with a zearalenone analog compound.
Patent AU-2008341666-B2 (AU)
Title: Method for increasing the therapeutic efficacy of curcuminoids and analogues
Inventor: SANCHEZ-COVISA VILLA ANGEL
IPC: A61K36/9066
Filed: 2008-12-19
Granted: 2013-10-03
Abstract: The invention relates to a method for increasing the therapeutic efficacy of curcuminoids and analogues. More specifically, the invention relates to a method for increasing the therapeutic efficacy of systemically administered formulations that contain curcuminoids and the equivalent therapeutics thereof. The method is characterised in that together with the administration of the formulation the patient is irradiated with visible-ultraviolet radiation. The invention also relates to phototherapy devices that emit visible radiation over a surface area greater than 0.2 m2 and irradiance of more than 2 mW/cm2, suitable for use in the treatment of proliferative diseases, particularly moderate-to-severe psoriasis or tumoral processes.
Patent AU-2008357927-B2 (AU)
Title: A power apparatus for a high voltage electrical power system
Inventor: NYGREN BERTIL
IPC: H02M1/32
Filed: 2008-06-17
Granted: 2014-01-30
Abstract: The invention relates to a power apparatus (1) for a high voltage electrical power system (19), the power apparatus comprising a voltage source converter (2) and a high voltage dc power source (3) comprising one or more strings (4a, 4b, 4c) including a plurality of dc power source members (20a-e) connected in series, and switches (9), (11, 13) configured to connect and disconnect said strings, where said switches are solid-state switches, each string is subdivided into a plurality of dc power source units (8, 10, 12), each dc power source unit including a plurality of dc power source members connected in series and each dc power source unit is provided with one of said solid-state switches configured to connect and disconnect the dc power source unit, and that all solid-state switches in the string are arranged so that they are turned on and off simultaneously.
Patent AU-2009209546-B2 (AU)
Title: Pharmaceutical composition with gelling properties containing a tyrosine derivative
Inventor: BASTIAT GUILLAUME
IPC: A61K9/06
Filed: 2009-01-30
Granted: 2013-12-19
Abstract: The present invention relates to an injectable pharmaceutical composition with gelling properties containing : - an active principle; a hydrophobic and bio-compatible organic liquid; and an organogelling substance, the molecules of which have the capacity to bind together via bonds of low energy, wherein said organogelling substance is chosen among L-tyrosine derivatives responding to the following formula (I) wherein : • R1 is an alkyl group containing 1 to 3 carbon atoms, linear or branched; and • R2 is a hydrophobic group chosen among aliphatic saturated or unsaturated fatty chains or aryl or arylalkyl groups, Its use as a vector for the release of active principles, as well as its process of preparation.
Patent AU-2009242503-B2 (AU)
Title: Rectal drain appliance
Inventor: GREGORY CHRISTOPHER
IPC: A61F5/44
Filed: 2009-05-01
Granted: 2014-11-20
Abstract: A rectal drainage appliance is disclosed comprising a tubular element having an inflatable balloon at a distal end for anchoring the appliance in the rectum. The appliance includes one or more of: (i) first and second auxiliary lumens communicating with the inflatable balloon to provide independent inflation and pressure monitoring paths coupled to the balloon; (ii) a pressure state indicator defined by a mechanical element configured to flip between first and second states or shapes responsive to sensed pressure; and (iii) a collapsible auxiliary lumen larger than the inflation lumen, and configured to permit admission of irrigation fluid. The pressure state indicator may also be used in intestinal drains.
Patent AU-2009308465-B2 (AU)
Title: Substituted pyrazolo[1,5-a]pyrimidine compounds as TRK kinase inhibitors
Inventor: HAAS JULIA
IPC: C07D471/04
Filed: 2009-10-21
Granted: 2015-02-12
Abstract: Compounds of Formula (I) in which R
Patent AU-2009315435-B2 (AU)
Title: Suppression of cancer
Inventor: MADEC FREDERIC
IPC: C07K14/33
Filed: 2009-11-17
Granted: 2015-10-08
Abstract: The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which is targeted to the cancer cell, and, when so delivered, the protease is internalised and inhibits secretion from the cancer cell.
Patent AU-2009332928-B2 (AU)
Title: A kind of biodegradable polyester and its preparation method
Inventor: XU YIBIN
IPC: A61L15/62
Filed: 2009-05-15
Granted: 2013-05-09
Abstract: The present invention relates to a kind of biodegradable polyester and its preparation method, which belongs to the field of biodegradable co-polyester product technology. The number-average molecular weight of the biodegradable 5 polyester material under this invention is 6000-135000g/mol, the molecular weight distribution is 1.2-6.5, and the range of crystallization temperature is 15'C-105'C, which could overcome the disadvantages of existing technical products and can be processed into membrane materials, sheet materials and foam materials. During processing, the picking property will be dramatically changed with the appearance 10 quality improved; after heat resistance is improved, this new type of polyester material could also be applied to the processing course with long cycles, for example, the injection processing course, and the biodegradable aliphatic/aromatic polyester materials provided by this invention has excellent mechanical properties.
Patent AU-2010221284-B2 (AU)
Title: Stabilized reverse transcriptase fusion proteins
Inventor: LAMBOWITZ ALAN M
IPC: C12N15/62
Filed: 2010-03-04
Granted: 2015-10-01
Abstract: Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse transcriptase. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.
Patent AU-2010221805-B2 (AU)
Title: Optical fiber drop terminal
Inventor: REAGAN RANDY
IPC: G02B6/44
Filed: 2010-09-16
Granted: 2012-09-13
Abstract: C UlR ,nbIDCCVAAS,3 114191-1.DOC-"/I6i201O A fiber drop terminal may include a housing having an outer surface containing a plurality of receptacles. The housing may include a lower surface and an inner cavity. 5 The fiber drop terminal may include a fiber storage cavity occupying a portion of the inner cavity. The storage cavity may store a plurality of fiber coils at an angle. 16001624B81626